U

VVT Medical

Varicose Vein Treatment
Startup Pre-Funding Founded 2007 Health Tech & Life Sciences
Last Update Aug 11, 2025

VVT Medical News

1 article
Apr 24, 2023 · www.vvtmed.com
growth-positive
VVT Medical Announces FDA 510(k) Submission for its ScleroSafe™ System - VVT MEDICAL Ltd
VVT Medical has submitted a 510(k) premarket notification to the FDA for their ScleroSafe™ System, an innovative medical device for managing varicosities in superficial veins. The product is already approved in multiple regions and has a proven track record of safety and effectiveness. Varicose veins affect millions of people in the US, highlighting the need for effective solutions. VVT Medical aims to revolutionize the treatment of varicose veins with their product. The CEO, Erez Tetro, believes it has the potential to positively impact the lives of millions of people worldwide. The company is committed to ensuring accessibility of the product to all patients in need.
Customers